Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.

Toon andere (1) versies

OBJECTIVES: The use of clinical staging in the fatal neurodegenerative disease amyotrophic lateral sclerosis would have value in optimising future therapeutic trials. We aimed to use previous clinical trial data to determine the length of time patients spend in each of four proposed stages, its rang...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Balendra, R, Jones, A, Jivraj, N, Steen, I, Young, C, Shaw, P, Turner, M, Leigh, P, Al-Chalabi, A
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2015

Gelijkaardige items

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
door: Balendra, R, et al.
Gepubliceerd in: (2015)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
door: Jones, A, et al.
Gepubliceerd in: (2014)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
door: Balendra, R, et al.
Gepubliceerd in: (2014)

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
door: Jones, A, et al.
Gepubliceerd in: (2013)

Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
door: Balendra, R, et al.
Gepubliceerd in: (2013)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
door: Turner, M, et al.
Gepubliceerd in: (2002)

A proposed staging system for amyotrophic lateral sclerosis.
door: Roche, J, et al.
Gepubliceerd in: (2012)

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
door: Turner, M, et al.
Gepubliceerd in: (2007)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
door: Al-Chalabi, A, et al.
Gepubliceerd in: (2003)

Biomarkers in amyotrophic lateral sclerosis.
door: Turner, M, et al.
Gepubliceerd in: (2009)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
door: Rutter-Locher, Z, et al.
Gepubliceerd in: (2016)

Amyotrophic lateral sclerosis
door: Leigh P Nigel, et al.
Gepubliceerd in: (2009-02-01)

Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients
door: Xueping Chen, et al.
Gepubliceerd in: (2018-06-01)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
door: Turner, M, et al.
Gepubliceerd in: (2020)

Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: Observational study
door: Garcia-Gancedo, L, et al.
Gepubliceerd in: (2019)

Evolution of white matter damage in amyotrophic lateral sclerosis
door: Gabel, M, et al.
Gepubliceerd in: (2020)

Amyotrophic lateral sclerosis and cerebellum
door: Renata Kabiljo, et al.
Gepubliceerd in: (2022-07-01)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
door: Turner, M, et al.
Gepubliceerd in: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
door: Turner, M, et al.
Gepubliceerd in: (2012)

Quantifying disease progression in amyotrophic lateral sclerosis.
door: Simon, N, et al.
Gepubliceerd in: (2014)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
door: Corcia P, et al.
Gepubliceerd in: (2012-08-01)

Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.
door: Johnston, C, et al.
Gepubliceerd in: (2006)

Clinical Controversies in Amyotrophic Lateral Sclerosis
door: Ruaridh Cameron Smail,, et al.
Gepubliceerd in: (2020-07-01)

Clinical psychology and amyotrophic lateral sclerosis
door: Francesco Pagnini, et al.
Gepubliceerd in: (2010-07-01)

Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study
door: Garcia-Gancedo, Luis, et al.
Gepubliceerd in: (2019-12-01)

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis
door: Henderson, R, et al.
Gepubliceerd in: (2018)

Evolution of white matter damage in amyotrophic lateral sclerosis
door: Matt C. Gabel, et al.
Gepubliceerd in: (2020-05-01)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
door: Abrahams, S, et al.
Gepubliceerd in: (1997)

Amyotrophic lateral sclerosis.
door: Kiernan, M, et al.
Gepubliceerd in: (2011)

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.
door: Scott, K, et al.
Gepubliceerd in: (2009)

Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis
door: Yildiz, O, et al.
Gepubliceerd in: (2025)

The reunification of amyotrophic lateral sclerosis
door: Turner, M
Gepubliceerd in: (2018)

Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis.
door: Turner, M, et al.
Gepubliceerd in: (2011)

Neuroimaging in amyotrophic lateral sclerosis.
door: Turner, M, et al.
Gepubliceerd in: (2012)

The sex ratio in amyotrophic lateral sclerosis: A population based study.
door: Manjaly, Z, et al.
Gepubliceerd in: (2010)

Clinical neurorestorative progress in amyotrophic lateral sclerosis
door: Chen L, et al.
Gepubliceerd in: (2015-08-01)

Progress in clinical diagnosis of amyotrophic lateral sclerosis
door: Qiong YANG, et al.
Gepubliceerd in: (2012-06-01)

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
door: Kelly, M, et al.
Gepubliceerd in: (2020)

Amyotrophic lateral sclerosis: Clinical heterogeneity and approaches to classification
door: I. S. Bakulin, et al.
Gepubliceerd in: (2017-11-01)

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.
door: Fang, F, et al.
Gepubliceerd in: (2013)